Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 118 to 167 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
118\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDUFA12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase subunit b17.2 (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b17.2) (ci-b17.2) (cib17.2) (13 kda differentiation-associated protein). [source:swissprot;acc:q9ui09]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
284.753\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.934\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.24382\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
119\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDUFS4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 18 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-18 kda) (ci-18 kda) (complex i- aqdq) (ci-aqdq). [source:swissprot;acc:o43181]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
318.982\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
259.004\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.23157\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
120\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCND2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 2; voltage-sensitive potassium channel; voltage-gated potassium channel kv4.2. [source:refseq;acc:nm\_012281]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.278\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
327.709\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21699\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CTH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cystathionine gamma-lyase (ec 4.4.1.1) (gamma-cystathionase). [source:swissprot;acc:p32929]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.254\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
327.655\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2169\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
122\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCND3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 3 isoform 1; sha1-related potassium channel kv4.3; voltage-gated k+ channel; potassium ionic channel kv4.3; voltage-gated potassium channel kv4.3. [source:refseq;acc:nm\_004980]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.248\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
327.642\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21688\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
123\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCND1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 1; shal-type potassium channel; voltage-gated potassium channel kv4.1. [source:refseq;acc:nm\_004979]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
269.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
327.601\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21681\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
124\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HMG20B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
high-mobility group 20b; sox-like transcriptional factor; swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily e, member 1-related. [source:refseq;acc:nm\_006339]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
171.595\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21519\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HMG20A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
high-mobility group 20a. [source:refseq;acc:nm\_018200]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.588\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
171.778\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21429\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STAMBPL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
associated molecule with the sh3 domain of stam (amsh) like protein. [source:refseq;acc:nm\_020799]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
94\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
114\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.21277\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
127\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHMP2A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative breast adenocarcinoma marker (32kd). [source:refseq;acc:nm\_014453]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
128\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STAMBP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
associated molecule with the sh3 domain of stam. [source:refseq;acc:nm\_006463]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
129\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VPS24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuroendocrine differentiation factor; comparative gene identification transcript 149. [source:refseq;acc:nm\_016079]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
130\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHMP4A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein hspc134 (protein cda04). [source:swissprot;acc:q9by43]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
131\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SON\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
son protein (son3) (negative regulatory element-binding protein) (nre- binding protein) (dbp-5) (bax antagonist selected in saccharomyces 1) (bass1) (protein c21orf50). [source:swissprot;acc:p18583]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
294.053\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
242.562\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.21228\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
132\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TOB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tob2 protein (transducer of erbb-2 2). [source:swissprot;acc:q14106]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
350\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
290\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.2069\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
133\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TOB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tob1 protein (transducer of erbb-2 1). [source:swissprot;acc:p50616]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
134\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DAB2IP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dab2 interacting protein; ngap-like protein; doc-2/dab2 interactive protein. [source:refseq;acc:nm\_032552]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
135\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPEB4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytoplasmic polyadenylation element binding protein 4. [source:refseq;acc:nm\_030627]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
136\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPEB3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytoplasmic polyadenylation element binding protein 3. [source:refseq;acc:nm\_014912]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
137\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RASAL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ras gtpase-activating protein ngap (ras protein activator like 1). [source:swissprot;acc:q9ujf2]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
138\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPP2CA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, catalytic subunit, alpha isoform (ec 3.1.3.16) (pp2a-alpha) (replication protein c) (rp-c). [source:swissprot;acc:p05323]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
194.372\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.204\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20493\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
139\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
APBA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
amyloid beta a4 precursor protein-binding family a member 1 (neuron- specific x11 protein) (neuronal munc18-1-interacting protein 1) (mint-1) (adapter protein x11alpha). [source:swissprot;acc:q02410]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
271.752\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20415\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
140\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RRAGA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ras-related gtp binding a; ras-related gtp-binding protein. [source:refseq;acc:nm\_006570]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
59\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
49\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.20408\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
141\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RRAGC\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ras-related gtp binding c; rag c protein. [source:refseq;acc:nm\_022157]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
142\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RRAGB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ras-related gtp binding b short isoform; gtp-binding protein ragb. [source:refseq;acc:nm\_006064]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
143\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ANLN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
anillin, actin binding protein (scraps homolog, drosophila); anillin (drosophila scraps homolog), actin binding protein. [source:refseq;acc:nm\_018685]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
144\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCNIP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kv channel interacting protein 1; vesicle apc-binding protein; a-type potassium channel modulatory protein 1. [source:refseq;acc:nm\_014592]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
265.686\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
319.651\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20312\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
145\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCNIP4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium channel-interacting protein 4 isoform 4; calsenilin-like protein. [source:refseq;acc:nm\_147183]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
265.639\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
319.546\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20293\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
146\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCNIP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kv channel interacting protein 2 isoform 4; a-type potassium channel modulatory protein 2; cardiac voltage gated potassium channel modulatory subunit. [source:refseq;acc:nm\_173193]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
265.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
319.531\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20291\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
147\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nuclear dna-binding protein; small unique nuclear receptor corepressor; c1d dna-binding protein. [source:refseq;acc:nm\_006333]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
50.7983\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
42.3003\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2009\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
148\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UNC84A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sad1/unc-84 protein-like 1. [source:swissprot;acc:o94901]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
296.677\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
247.559\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19841\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
149\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atlastin; guanylate-binding protein 3. [source:refseq;acc:nm\_015915]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
142\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.19718\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
150\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYO5B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin vb (myosin 5b) (fragment). [source:swissprot;acc:q9ulv0]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
55\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
46\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.19565\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
151\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYO5C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin vc (myosin 5c). [source:swissprot;acc:q9nqx4]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
152\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin va (myosin 5a) (dilute myosin heavy chain, non-muscle) (myosin heavy chain 12) (myoxin). [source:swissprot;acc:q9y4i1]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
153\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBM15B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
chromosome 3p21.1 gene sequence. [source:refseq;acc:nm\_013286]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
249.663\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
298.263\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.19466\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
154\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RGS19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
regulator of g-protein signaling 19 (rgs19) (g-alpha interacting protein) (gaip protein). [source:swissprot;acc:p49795]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
155\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RBM15\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative rna-binding protein 15 (rna binding motif protein 15) (one-twenty two protein). [source:swissprot;acc:q96t37]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
156\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RGS20\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
regulator of g-protein signaling 20 (rgs20) (regulator of gz- selective protein signaling 1) (gz-selective gtpase-activating protein) (g(z)gap). [source:swissprot;acc:o76081]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
157\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LBX1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor lbx1. [source:swissprot;acc:p52954]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
158\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GPSM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mosaic protein lgn. [source:swissprot;acc:p81274]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
159\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RGS17\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
regulator of g-protein signaling 17 (rgs17). [source:swissprot;acc:q9ugc6]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
160\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GNAO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(o), alpha subunit 1. [source:swissprot;acc:p09471]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
161\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAP1GAP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rap1 gtpase-activating protein 1 (rap1gap). [source:swissprot;acc:p47736]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
162\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NOSTRIN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nostrin. [source:refseq;acc:nm\_052946]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
209.299\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
249.187\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.19058\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
163\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNF8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eap30 subunit of ell complex. [source:refseq;acc:nm\_007241]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
164\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC39A6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
liv-1 protein, estrogen regulated. [source:refseq;acc:nm\_012319]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
165\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutamate decarboxylase, 65 kda isoform (ec 4.1.1.15) (gad-65) (65 kda glutamic acid decarboxylase). [source:swissprot;acc:q05329]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
166\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NAPG\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gamma-soluble nsf attachment protein (snap-gamma) (n-ethylmaleimide- sensitive factor attachment protein, gamma). [source:swissprot;acc:q99747]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
167\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutamate decarboxylase, 67 kda isoform (ec 4.1.1.15) (gad-67) (67 kda glutamic acid decarboxylase). [source:swissprot;acc:q99259]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/